Wang Jeffrey C, Kanim Linda E A, Yoo Stephen, Campbell Patricia A, Berk Arnold J, Lieberman Jay R
Department of Orthopaedic Surgery, University of California at Los Angeles, School of Medicine, 90095-6902, USA.
J Bone Joint Surg Am. 2003 May;85(5):905-11. doi: 10.2106/00004623-200305000-00020.
Bone morphogenetic proteins (BMPs) are now being used as bone-graft substitutes to enhance spinal fusion. However, the large doses of BMP required to induce a spinal fusion in humans suggests that the delivery of these proteins should be improved. We used ex vivo adenoviral gene transfer to create BMP-2-producing bone marrow cells, and these autologous cells were found to induce a posterolateral fusion of the spine in syngeneic rats.
Intertransverse spinal arthrodesis (L4 and L5) was attempted in ten groups of Lewis rats with 5 x 10 (6) BMP-2-producing rat bone marrow cells (Ad-BMP-2 cells), created through adenoviral gene transfer with guanidine hydrochloride-extracted demineralized bone matrix as a carrier (Group I); 5 x 10 (6) Ad-BMP-2 cells on a collagen sponge carrier (Group II); 10 micro g of recombinant BMP-2 (rhBMP-2) in a guanidine hydrochloride-extracted demineralized bone matrix carrier (Group III); 10 micro g of rhBMP-2 in a collagen sponge carrier (Group IV); autogenous iliac crest bone-grafting (Group V); 5 x 10 (6) beta-galactosidase-producing rat bone marrow cells, created through adenoviral gene transfer with guanidine hydrochloride-extracted demineralized bone matrix as a carrier (Group VI); decortication of the transverse processes alone (Group VII); 5 x 10 (6) uninfected rat bone marrow cells with a guanidine hydrochloride-extracted demineralized bone matrix carrier (Group VIII); guanidine hydrochloride-extracted demineralized bone matrix only (Group IX); or a collagen sponge alone (Group X). Each specimen underwent plain radiography, manual palpation, and histological analysis.
All spines in Groups I and II (BMP-2-producing bone marrow cells) and all spines in Groups III and IV were fused at four weeks postoperatively. In contrast, none of the spines in the other groups had fused at a minimum of eight weeks after implantation. Histological analysis of the specimens revealed that the spines that had received BMP-2-producing bone marrow cells (Groups I and II) were filled with coarse trabecular bone postoperatively, whereas those that had received rhBMP-2 (Groups III and IV) were filled with thin, lace-like trabecular bone. All of the other spines, including those that had been treated with autogenous iliac crest bone-grafting (Group V), produced little or no new bone.
BMP-2-producing bone marrow cells, created by adenoviral gene transfer, produce sufficient BMP to induce an intertransverse fusion in the rat spine model.
骨形态发生蛋白(BMPs)目前正被用作骨移植替代物以增强脊柱融合。然而,在人类中诱导脊柱融合所需的大剂量BMP表明这些蛋白质的递送方式应加以改进。我们利用离体腺病毒基因转移来制备产生BMP-2的骨髓细胞,并且发现这些自体细胞可在同基因大鼠中诱导脊柱后外侧融合。
对十组Lewis大鼠尝试进行横突间脊柱融合术(L4和L5),其中,通过以盐酸胍提取的脱矿骨基质为载体的腺病毒基因转移制备的5×10⁶个产生BMP-2的大鼠骨髓细胞(Ad-BMP-2细胞)(第一组);胶原海绵载体上的5×10⁶个Ad-BMP-2细胞(第二组);盐酸胍提取的脱矿骨基质载体中的10μg重组BMP-2(rhBMP-2)(第三组);胶原海绵载体中的10μg rhBMP-2(第四组);自体髂骨移植(第五组);通过以盐酸胍提取的脱矿骨基质为载体的腺病毒基因转移制备的5×10⁶个产生β-半乳糖苷酶的大鼠骨髓细胞(第六组);仅对横突进行去皮质处理(第七组);盐酸胍提取的脱矿骨基质载体中的5×10⁶个未感染的大鼠骨髓细胞(第八组);仅盐酸胍提取的脱矿骨基质(第九组);或仅胶原海绵(第十组)。每个标本均接受X线平片、手动触诊和组织学分析。
第一组和第二组(产生BMP-2的骨髓细胞)的所有脊柱以及第三组和第四组的所有脊柱在术后四周均融合。相比之下,其他组的脊柱在植入后至少八周均未融合。标本的组织学分析显示,接受产生BMP-2的骨髓细胞的脊柱(第一组和第二组)术后充满粗大的小梁骨,而接受rhBMP-2的脊柱(第三组和第四组)充满细小的、花边样小梁骨。所有其他脊柱,包括接受自体髂骨移植治疗的脊柱(第五组),几乎没有产生新骨或未产生新骨。
通过腺病毒基因转移制备的产生BMP-2的骨髓细胞可产生足够的BMP以在大鼠脊柱模型中诱导横突间融合。